Eric K. Rowinsky, Chief Medical Officer at STEMLINE THERAPEUTICS INC (STML), sold 10,824 shares at $15.77 ($171K) on 2015-04-27, disclosed to the SEC on 2015-04-28.
Open-market sale of $171k STML by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FBIO | BUY | 2023-02-14 | $10K | — | Filing → |
| FBIO | SELL | 2021-04-09 | $127K | — | Filing → |
| BIIB | SELL | 2015-03-23 | $5.5M | — | Filing → |